TVR

Summary by AI BETAClose X

Brave Bison Group PLC has announced an update to its equity issuance, correcting a clerical error to now receive 2,905,899 ordinary shares in System1 in exchange for 9,763,821 Brave Bison shares, maintaining its 28% holding in System1. Application has been made for these 9,763,821 new ordinary shares to be admitted to AIM on 4 March 2026, which will represent 8.7% of the enlarged issued share capital. Following admission, the Company will have a total of 112,238,119 ordinary shares in issue, a figure shareholders can use for disclosure notifications.

Disclaimer*

Brave Bison Group PLC
03 March 2026
 

 

Brave Bison Group plc

 

("Brave Bison" or the "Company", together with its subsidiaries "the Group") 

 

Total Voting Rights

 

and

 

Update to Issue of Equity

 

Pursuant to the announcement dated 2 March 2026 and as a result of a clerical error, the Group will now be receiving a total of 2,905,899 ordinary shares in System1 in exchange for 9,763,821 ordinary shares in Brave Bison. The Group's resultant shareholding of 28% in in System1 remains materially unchanged.

 

As a result, application has been made for the revised total of 9,763,821 new ordinary shares, to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 4 March 2026 and the new ordinary shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares. The new ordinary shares in Brave Bison will represent 8.7% of the Group's enlarged issued share capital following Admission.

 

On Admission, the Company will have a total of 112,238,119 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 112,238,119 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

For further information please contact:  

 

Brave Bison Group plc                                                                                                 via Cavendish 

Oliver Green, Executive Chairman                                                           

Theo Green, Chief Growth Officer  

Philippa Norridge, Chief Financial Officer  

 

Cavendish Capital Markets                                                                                         Tel: +44 (0) 20 7220 0500 

Nominated Adviser & Joint Broker  

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance 

Michael Johnson / Sunila de Silva - ECM

 

Singer Capital Markets                                                                                                 Tel: +44 (0) 20 7496 3000 

Joint Broker  

Alex Bond / Sara Hale

 

About Brave Bison 

 

Brave Bison is a media, marketing and technology partner for global brands. With operations across eight countries including the UK, US, India, Australia and Egypt, Brave Bison supports customers with marketing consultancy, execution and training services via a connected, AI-enabled operating model.

 

The company operates through three divisions: marketing consultancy, marketing training and sport and entertainment. The marketing consultancy division designs and deploys bespoke, insight-led and AI-enabled growth strategies for global brands and businesses including New Balance, Primark and Google via specialist agencies including SocialChain and MTM. The sport and entertainment division monetises content and scales communities for the biggest creators, teams and federations on the planet-from Real Madrid to the US Open. Finally, the marketing training division, MiniMBA, is an eLearning platform offering industry-leading MBA-level training in brand, marketing and business strategy for leading global enterprises such as Carlsberg, Nestlé and Salesforce.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings